Bidadari Tak Bersayap
[Intro] D Dsus4 Bm E
G F#m Em Asus4 A Dsus4 D
[Verse]
D Gm Bm E
Bidadari tak bersayap datang padaku
G D/F# D/B Em A D
Dikirim Tuhan dalam wujud wajah kamu
G D/F# D/B Em A D
Dikirim Tuhan dalam wujud diri kamu
D Gm Bm E
Sungguh tenang ku rasa saat bersamamu
G D/F# D/B Em A D
Sederhana namun indah kau mencintaiku
G D/F# D/B Em A D
Sederhana namun indah kau mencintaiku
[Chorus]
D A G D
Sampai habis umurku sampai habis usia
A Bm G D
Maukah dirimu jadi teman hidupku
D A G D
Kaulah satu di hati kau yang teristimewa
A Bm G A D
Maukah dirimu hidup denganku
[Verse]
D Gm Bm E
Diam-diam aku memandangi wajahnya
G D/F# D/B Em A D
Tuhan ku sayang sekali wanita ini
G D/F# D/B Em A D
Tuhan ku sayang sekali wanita ini
[Chorus]
D A G D
Sampai habis umurku sampai habis usia
A Bm G D
Maukah dirimu jadi teman hidupku
D A G D
Kaulah satu di hati kau yang teristimewa
A Bm G A D
Maukah dirimu hidup denganku
[Post-Chorus]
G A Bm
Katakan yes, I do
G A Bm
jadi teman hidupku
G A D G A D
Dududududu dududududu dududu
[Interlude] D A G D
A F# Bm A G A D
A F# Bm A G A
[Chorus]
D A G D
Sampai habis umurku sampai habis usia
A Bm G D
Maukah dirimu jadi teman hidupku
D A G D
Kaulah satu di hati kau yang teristimewa
A F# Bm A G A D
Maukah dirimu hidup denganku
[Post-Chorus]
G A Bm
Katakan yes, I do
G A Bm
jadi teman hidupku
G A D
Katakan yes, I do
G A D
Hiduplah denganku
G A D
jadi teman hidupku
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment